Oak Ridge Investments LLC Abbott Laboratories Transaction History

Oak Ridge Investments LLC

$1.25 Billion
Q4 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$109.52 - $120.96 $204,692 - $226,074	1,869 Added 4.77%	41,011 $4.66 Million
Q4 2023 Jan 16, 2024	BUY	$90.19 - $110.4 $30,754 - $37,646	341 Added 0.88%	39,142 $4.31 Million
Q3 2023 Oct 30, 2023	BUY	$95.53 - $114.62 $165,649 - $198,751	1,734 Added 4.68%	38,801 $3.76 Million
Q2 2023 Aug 07, 2023	SELL	$100.78 - $112.29 $21,365 - $23,805	-212 Reduced 0.57%	37,067 $4.04 Million
Q1 2023 Apr 14, 2023	SELL	$96.86 - $114.01 $5,811 - $6,840	-60 Reduced 0.16%	37,279 $3.77 Million
Q4 2022 Jan 24, 2023	SELL	$95.06 - $111.52 $54,754 - $64,235	-576 Reduced 1.52%	37,339 $0
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $79,149 - $91,640	-818 Reduced 2.11%	37,915 $3.67 Million
Q2 2022 Jul 28, 2022	SELL	$102.07 - $123.37 $125,137 - $151,251	-1,226 Reduced 3.07%	38,733 $4.21 Million
Q1 2022 Apr 22, 2022	SELL	$114.02 - $139.04 $78,445 - $95,659	-688 Reduced 1.69%	39,959 $4.73 Million
Q4 2021 Feb 01, 2022	SELL	$115.53 - $141.46 $82,026 - $100,436	-710 Reduced 1.72%	40,647 $5.72 Million
Q3 2021 Nov 05, 2021	SELL	$116.66 - $129.06 $102,894 - $113,830	-882 Reduced 2.09%	41,357 $4.89 Million
Q2 2021 Jul 30, 2021	SELL	$105.79 - $124.53 $93,200 - $109,710	-881 Reduced 2.04%	42,239 $4.9 Million
Q1 2021 May 12, 2021	SELL	$108.84 - $128.23 $49.2 Million - $57.9 Million	-451,727 Reduced 91.29%	43,120 $5.17 Million
Q1 2021 May 04, 2021	BUY	$108.84 - $128.23 $49.2 Million - $57.9 Million	451,887 Added 1051.88%	494,847 $59.3 Million
Q4 2020 Feb 03, 2021	SELL	$105.0 - $114.42 $2.01 Million - $2.19 Million	-19,137 Reduced 30.82%	42,960 $4.7 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $61,032 - $74,119	-666 Reduced 1.06%	62,097 $6.76 Million
Q2 2020 Aug 05, 2020	SELL	$76.57 - $98.0 $50,306 - $64,386	-657 Reduced 1.04%	62,763 $5.74 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $409,963 - $599,478	-6,526 Reduced 9.33%	63,420 $5 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $276,041 - $307,298	-3,516 Reduced 4.79%	69,946 $6.08 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $77,993 - $84,569	-953 Reduced 1.28%	73,462 $6.15 Million
Q2 2019 Aug 14, 2019	SELL	$72.88 - $85.0 $423,505 - $493,935	-5,811 Reduced 7.24%	74,415 $6.26 Million
Q1 2019 May 09, 2019	BUY	$66.22 - $80.06 $5.31 Million - $6.42 Million	80,226 New	80,226 $6.41 Million

Others Institutions Holding ABT

# of Institutions

3,336

Shares Held

1.36B

Call Options Held

10M

Put Options Held

9.48M

Vanguard Group Inc Valley Forge, PA

169M
Shares

$22 Billion
0.34% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$17.1 Billion
0.31% of portfolio
State Street Corp Boston, MA

77.2M
Shares

$10.1 Billion
0.35% of portfolio
Capital International Investors Los Angeles, CA

68M
Shares

$8.88 Billion
1.51% of portfolio
Capital Research Global Investors Los Angeles, CA

54.1M
Shares

$7.07 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Ridge Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oak Ridge Investments LLC with notifications on news.

Account